WSX-1 plays a significant role for the initiation of experimental autoimmune uveitis

International Immunology

Volumn 19, Issue 1, 2007, Pages 93-98

  Sonoda, Koh Hei ^a   Yoshimura, Takeru ^a,b   Takeda, Atsunobu ^a   Ishibashi, Tatsuro ^a   Hamano, Shinjiro ^a   Yoshida, Hiroki ^c,d  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d SAGA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 27 RECEPTOR; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; PROTEIN WSX 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE TRANSMISSION; FEMALE; IMMUNOPATHOGENESIS; KNOCKOUT MOUSE; LYMPHOCYTE FUNCTION; LYMPHOCYTE TRANSFER; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; T LYMPHOCYTE; TH1 CELL; UVEITIS; WILD TYPE;

ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; INTERFERON TYPE II; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CYTOKINE; TH1 CELLS; UVEITIS;

EID: 33845868194     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl125     Document Type: Article

References (24)

1. Chen, Q., Ghilardi, N., Wang, H. et al. 2000. Development of Th 1-type immune responses requires the type I cytokine receptor TCCR. Nature 407:916.
2. Yoshida, H., Hamano, S., Senaldi, G. et al. 2001. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15:569.
3. Takeda, A., Hamano, S., Yamanaka, A. et al. 2003. Role of IL-27/WSX-1 signaling for induction of T-Bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170:4886.
4. Pflanz, S., Timans, J. C., Cheung, J. et al. 2002. IL-27, a heterodimeric cytokine composed of EB13 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16:779.
5. Gery, I., Wiggert, B., Redmond, T. M. et al. 1986. Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein. Investig. Ophthalmol. Vis. Sci. 27:1296.
6. Broekhuyse, R. M., Winkens, H. J. and Kuhlmann, E. D. 1986. Induction of experimental autoimmune uveoretinitis and pinealitis by IRBP. Comparison to uveoretinitis induced by S-antigen and opsin. Curr. Eye Res. 5:231.
7. de Smet, M. D., Yamamoto, J. H., Mochizuki, M. et al. 1990. Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am. J. Ophthalmol. 110:135.
8. Nussenblatt, R. B. 1987. Basic and clinical immunology in uveitis. JPN. J. Ophthalmol. 31:368.
9. Sun, B., Sun, S. H., Chan, C. C., Wiggert, B. and Caspi, R. R. 1999. Autoimmunity to a pathogenic retinal antigen begins as a balanced cytokine response that polarizes towards type 1 in a disease-susceptible and towards type 2 in a disease-resistant genotype. Int. Immunol. 11:1307.
10. Wu, Y., Lin, G. and Sun, B. 2003. IRBP-specific Th1 cells from peripheral blood were predominant in the experimental autoimmune uveitis. Biochem. Biophys. Res. Common. 302:150.
11. Yokoi, H., Kato, K., Kezuka, T. et al. 1997. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12. Eur. J. Immunol. 27:641.
12. Avichezer, D., Silver, P. B., Chan, C. C., Wiggert, B. and Caspi, R. R. 2000. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype. Investig. Ophthalmol. Vis. Sci. 41:127.
13. Thurau, S. R., Chan, C. C., Nussenblatt, R. B. and Caspi, R. R. 1997. Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): Induction of protective tolerance in primed animals. Clin. Exp. Immunol. 109:370.
14. Caspi, R. R., Roberge, F. G., Chan, C. C. et al. 1988. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J. Immunol. 140:1490.
15. Sonoda, K. H., Sasa, Y., Qiao, H. et al. 2003. Immunoregulatory role of ocular macrophages: The macrophages produce RANTES to suppress experimental autoimmune uveitis. J. Immunol. 171:2652.
16. Keino, H., Takeuchi, M., Kezuka, T., Yamakawa, N., Tsukahara, R. and Usui, M. 2003. Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice. Graefe's Arch. Clin. Exp. Ophthalmol. 241:111.
17. Sorensen, T. L., Tani, M., Jensen, J. et al. 1999. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103:807.
18. Sakane, T., Suzuki, N. and Nagafuchi, H. 1997. Etiopathology of Behcet's disease: Immunological aspects. Yonsei Med. J. 38:350.
19. Tarrant, T. K., Silver, P. B., Chan, C. C., Wiggert, B. and Caspi, R. R. 1998. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis. J. Immunol. 161:122.
20. Brombacher, F., Kastelein, R. A. and Alber, G. 2003. Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol. 24:207.
21. Hamano, S., Himeno, K., Miyazaki, Y. et al. 2003. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 19:657.
22. Villarino, A., Hibbert, L., Lieberman, L. et al. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19:645.
23. + T cells partially through STAT3-dependent mechanism. J. Immunol. 177:5377.
24. Jones, L. S., Rizzo, L. V. and Agarwal, R. K. 1997. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J. Immunol. 158:5997.